ADH Histidine Mutants for Cleaner Ni-NTA Protein Purification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing protein purification methods using Ni-NTA resin are hindered by non-target proteins with histidine residues binding to the resin, leading to impurities in the target protein preparation.

Innovation Solution

Engineering histidine residues of non-target proteins to reduce their affinity for Ni-NTA resin by mutating them to basic amino acids such as lysine, asparagine, or arginine, specifically in alcohol dehydrogenase (ADH) proteins at key positions, thereby enhancing the purity of target proteins.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If Ni-NTA resin is used for affinity chromatography purification, then target proteins with histidine tags can be purified, but non-target proteins with histidine residues also bind to the resin causing impurities

Engineering Contradiction:
Improvepurity of target proteinVSAvoidnon-specific binding of non-target proteins
Core Design Contradiction:
Manufacturing precisionVSObject-generated harmful factors

Solution Approach 1:

The patent applies parameter changes by mutating histidine residues to other amino acid residues (such as lysine, arginine, or alanine) at specific positions in non-target proteins. This changes the chemical properties of the protein surface, eliminating the coordination ability with nickel ions while maintaining the protein's native structure and function. The mutation strategy specifically targets histidine residues that are not involved in catalytic activity but are responsible for non-specific binding to Ni-NTA resin.

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If histidine residues are mutated to eliminate binding to Ni medium, then purity of target protein improves, but enzymatic activity may be affected

Engineering Contradiction:
Improvepurity of target proteinVSAvoidenzymatic activity of mutant protein
Core Design Contradiction:
Manufacturing precisionVSReliability

Solution Approach 1:

The patent applies local quality by differentiating between different functional regions of the protein. Histidine residues are selectively mutated only in non-catalytic regions or regions not involved in substrate binding, while catalytic histidine residues are preserved. This localized approach ensures that the mutation eliminates non-specific binding without affecting the enzyme's catalytic function. The patent identifies specific positions for mutation based on structural and functional analysis.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The mutant ADH proteins exhibit reduced binding to Ni-NTA resin, improving the expression purity, efficiency, and yield of target proteins in cell-free synthesis systems while maintaining enzymatic activity.

Implementation Method 1

the corresponding imidazolyl group, thiol group or indolyl group can form coordination bond with metal ion

Methodology Applied
Scientific EffectCoordination bond binding: Chemical Bonding

Implementation Method 2

The principle of immobilized metal-chelating affinity chromatography (IMAC) is mainly based on the fact that amino acid residues on protein surface can form different affinity with metal ions, which can be divided into three types: electrostatic attraction, covalent binding and coordination bond binding

Methodology Applied
Scientific EffectElectrostatic attraction: Electrostatics

Implementation Method 3

Affinity chromatography refers to a method that one of two molecules having affinity is fixed on an insoluble matrix, and the other molecule is separated and purified based on the specificity and reversibility of the affinity between the two molecules

Methodology Applied
Scientific EffectAffinity chromatography: Chromatography

Implementation Method 4

some non-target proteins also have several discontinuous histidine residues on the surface of their three-dimensional structure, which results in that those non-target proteins also bind to Ni-NTA resin

Methodology Applied
Scientific EffectAdsorption: Adsorption

Data Source

PatentUS12540313B2ADH protein family mutant and use thereof
Publication Date: 2026.02.03 KANGMA (SHANGHAI) BIOTECH LTD
  • US12540313B2 patent drawing
  • US12540313B2 patent drawing
  • US12540313B2 patent drawing

AI summary

Provided are an ADH protein mutant and the use thereof. Compared with a wild-type ADH protein, the mutant is capable of (i) enhancing the expression purity, efficiency and yield of exogenous proteins in an in-vitro cell-free synthesis system; and/or (ii) reducing the binding ability of the mutant protein to Ni medium.